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Globalization, International Law, and
Emerging Infectious Diseases
David P. Fidler, J.D.
Indiana University School of Law,
Bloomington, Indiana, USA
The global nature of the threat posed by new and reemerging infectious diseases will
require international cooperation in identifying, controlling, and preventing these diseases.
Because of this need for international cooperation, international law will certainly play a role
in the global strategy for the control of emerging diseases. Recognizing this fact, the World
Health Organization has already proposed revising the International Health Regulations.
This article examines some basic problems that the global campaign against emerging
infectious diseases might face in applying international law to facilitate international coop-
eration. The international legal component of the global control strategy for these diseases
needs careful attention because of problems inherent in international law, especially as it
applies to emerging infections issues.
The growing literature on new and reemerging
infectious diseases often emphasizes the global
nature of their threat; the U.S. Centers for Disease
Control and Prevention (CDC) defines these dis-
eases as “diseases of infectious origin whose inci-
dence in humans has increased within the past
two decades or threatens to increase in the near
future" (1). The World Health Organization has
asserted that emerging infections “represent a
global threat that will require a coordinated,
global response” (2). The threat is global because
a disease can emerge anywhere on the planet and
spread quickly to other regions through trade and
travel. The global challenge of emerging infections
has serious consequences for national and inter-
national law; a state’s ability to deal with them is
eroded because microbes do not respect interna-
tionally recognized borders (3). Experts grappling
with these diseases no longer consider that the
pursuit of a strictly national public health policy
is adequate. The need for global cooperation in-
creases the importance of international law in the
public health arena. Part of the effort to create a
global response to emerging infections should be
an understanding of the problems that may arise
from relying on international law in dealing with
these diseases. This article outlines issues that
will have to be confronted in using international
law to combat emerging infections.
Globalization
The assertion that emerging infections are a
global problem requiring a global strategy echoes
observations made in other spheres of public pol-
icy: the traditional distinctions between national
and international political, social, and economic
activities are losing their importance (4). Globali-
zation is eroding traditional distinctions between
domestic and foreign affairs. Globalization has
been defined as the “process of denationalization
of markets, laws, and politics in the sense of inter-
lacing peoples and individuals for the sake of the
common good” (5). Globalization is distinguished
from internationalization, which is defined “as a
means to enable nation-states to satisfy the na-
tional interest in areas where they are incapable
of doing so on their own” (5). Internationalization
involves cooperation between sovereign states,
whereas globalization refers to a process that is
undermining or eroding sovereignty.
Globalization arises from the confluence of
something old and something new in international
relations. It involves the very old process of politi-
cal and economic intercourse among sovereign
states. The new element is the intensification and
expansion of such intercourse made possible by
technological advances in travel, communications,
and computers. Encouraging such intensification
and expansion is liberal economic thinking, which
posits that economic interdependence makes all
states economically better off and builds order and
peace in the international system (6).
The changes wrought by new technologies un-
leashed in the receptive international milieu
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created by liberal trade and economic policies have
led to the belief that these developments are un-
dermining sovereignty. Observers of international
relations frequently note that governments no
longer have control over economic forces at work
within their countries. The speed and volume of
international capital flows illustrate the denation-
alization of economics occurring through the proc-
ess of globalization (7). Another example is the
development of the global company—an enter-
prise that can no longer be considered national
because of the global reach of its operations, fi-
nancing options, markets, and strategies (7). The
globalization of finance and business has ramifi-
cations for politics and law as leaders and legal
systems adapt to the global era (8).
In public health, a similar combination of old
and new factors can be seen. States have histori-
cally cooperated on infectious disease control, first
through international sanitary treaties and later
through the World Health Organization (WHO)
(9). While international cooperation is not new,
current global circumstances confronting the con-
trol of infectious disease are. Globalization is also
at work in public health. The assertion that a
country cannot tackle emerging infectious dis-
eases by itself demonstrates that public health
policy has been denationalized.
Globalization has affected public health in
three ways. First, the shrinking of the world by
technology and economic interdependence allows
diseases to spread globally at rapid speed. Two
factors contributing to the global threat from
emerging infections stem directly from globaliza-
tion: the increase in international travel (2,10) and
the increasingly global nature of food handling,
processing, and sales (2, 10). HIV/AIDS, tubercu-
losis, cholera, and malaria represent a few infec-
tions that have spread to new regions through
global travel and trade (10). The beneficial eco-
nomic and political consequences of economic in-
terdependence may have negative ramifications
for disease control. In the European Union, for
example, the free movement of goods, capital, and
labor makes it more difficult for member states to
protect domestic populations from diseases ac-
quired in other countries (11).
Second, the development of the global market
has intensified economic competition and in-
creased pressure on governments to reduce expen-
ditures, including the funding of public health
programs, leaving states increasingly unprepared
to deal with emerging disease problems.
Industrialized as well as developing countries con-
front deteriorating public health infrastructures
(12). Referring to the United States, one author
described this deterioration as the “thirdworldiza-
tion” of the American health care system (13).
Third, public health programs have also “gone
global” through WHO and health-related nongov-
ernmental organizations. Medical advances have
spread across the planet, improving health world-
wide. The worldwide eradication of smallpox in
1977 is a famous example. The global reach of
health care advances has, however, a darker side.
The globalization of disease control has contrib-
uted to the population crisis because people are
living longer. Overpopulation creates fertile condi-
tions for the spread of disease: overcrowding, lack
of adequate sanitation, and overstretched public
health infrastructures (2). Further, the wide-
spread use and misuse of antibiotic treatments
has contributed to the development of drug-resis-
tant pathogens (1, 2).Finally, the success of control
efforts in previous decades caused interest in in-
fectious diseases to wane in the international
medical and scientific communities and is now
hampering emerging infectious disease control ef-
forts (14).
International Solutions to Emerging Infections
International efforts are under way to respond
to the threat of emerging infectious diseases.WHO
and CDC have drafted action plans that stress the
need to strengthen global surveillance of these
diseases and to allow the international community
to anticipate, recognize, control, and prevent them
(1, 14, 15). WHO has also established a new unit
to control and prevent emerging infections by mo-
bilizing resources rapidly at the first signs of out-
breaks (16). The Pan American Health
Organization has also adopted a regional plan for
controlling emerging infections in the Americas
(17). Health authorities from Central American
countries have adopted an emergency plan to con-
trol the epidemics of dengue and dengue hemor-
rhagic fever that recently swept through Central
and South America (18). Physicians in the Euro-
pean Union recognize the need for better surveil-
lance of infectious diseases (11).A U.S.government
interagency working group has underlined the
importance of international cooperation in dealing
with the emerging infections threat (19). The U.S.
Senate Labor and Human Resources Committee
held hearings in October 1995 on “Emerging In-
fections: A Significant Threat to the Health of the
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Nation” (20). At the Halifax Summit in 1995, the
major industrialized countries adopted a pilot pro-
ject called “Toward a Global Health Network” de-
signed to help governments deal with emerging
infections and other health problems (19) (Table
1). Clearly, the emerging infections threat and the
need for action are on the international diplomatic
and public health agendas.
Although international control plans would in-
volve private organizations like universities and
nongovernmental organizations, the primary ac-
tors on the emerging infections stage are sovereign
states. The action plans are predominantly blue-
prints for cooperation among states and represent
a call for the internationalization of responses to
a problem caused by globalization. Put another
way, the proposed solutions to the emerging infec-
tions threat rely on the sovereign state, while the
threat feeds off the impotence of the state in ad-
dressing global disease problems. When it comes
to public health activities, globalization erodes
sovereignty, but the proposed solution makes sov-
ereignty and its exercise critical to dealing with
the threat of emerging infections.
The consequences of the unavoidable emphasis
on international cooperation in the proposed ac-
tion plans for emerging infections are troubling.To
achieve the desired objectives (Table 1), states will
have to agree on many issues and translate such
agreement into guidelines or rules. International
law becomes important to the effort for emerging
infections control. Political leaders, diplomats, and
scholars have long recognized the weakness of
international law in regulating state behavior. At
first glance, the prospect of having to rely on a
notoriously weak institution of international rela-
tions as part of the global effort to combat emerg-
ing infections is unsettling.
International Law and Infectious Disease Control
We might have been less unsettled if our expe-
rience with international law in controlling infec-
tious diseases had been more positive. The success
of WHO in globalizing disease control programs
might suggest that the defects of international law
have not hobbled its effectiveness in improving
health care worldwide. However, despite having
the authority to do so, WHO has been reluctant to
use international law (21, 22). The International
Health Regulations administered by WHO repre-
sent the most important set of international legal
rules relating to infectious disease control, but the
regulations only apply to plague, yellow fever, and
cholera (23). The importance of health is men-
tioned in international declarations (for example,
see the Universal Declaration of Human Rights,
art. 25 [1]) and treaties (for example, see the Inter-
national Covenant on Economic, Social and Cul-
tural Rights, art. 12), leading some legal scholars
to argue that international law creates a “right to
health” (24); but this “right” does not directly ad-
dress the control of infectious diseases. WHO has
refrained from adopting rules on trade in human
blood and organs, which does raise issues of infec-
tious disease control as illustrated by the sale of
HIV-contaminated blood in international com-
merce (25). Issues of disease control also appear in
specialized treaty regimes outside WHO, such as
treaties controlling marine pollution from ships
(26). Other areas of international public health
law, for example, rules about infant formula and
guidelines on pharmaceutical safety, do not deal
with the control of infectious diseases (25).
The effectiveness of existing international law
on infectious disease control has been questioned.
A 1975 WHO publication stated that the Interna-
tional Health Regulations have not functioned
satisfactorily at times of serious disease outbreaks
(27). More recently, WHO’s efforts with the Inter-
national Health Regulations have been called a
failure, and noncompliance with these regulations
Table 1. Some common elements of global emerging-disease
control plans
Strengthen international surveillance networks to
detect, control, and reduce emerging diseases.
Improve the international public health infrastruc-
ture (e.g., laboratories, research facilities, technology,
and communications links).
Develop better international standards, guidelines,
and recommendations.
Improve international capabilities to respond to dis-
ease outbreaks with adequate medical and scientific
resources and expertise.
Strengthen international research efforts on emerg-
ing diseases, particularly with regards to antibiotic-
resistant strains of diseases.
Focus attention and resources on training and sup-
porting medical and scientific expertise.
Encourage national governments to improve their
public health care systems,devote resources to eliminat-
ing or controlling causes of emerging diseases and coor-
dinate their public health activities with WHO and the
international community.
Sources: refs. 1, 14, 15, 19.
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has increased in connection with reporting disease
outbreaks (25). The HIV/AIDs crisis dramatically
illustrated the weaknesses of the health regula-
tions. Since AIDs was not originally (or sub-
sequently) made subject to the regulations, states
had, and continue to have, no notification require-
ments in connection with this new disease. Fur-
ther, as HIV/AIDs spread globally, many states
adopted exclusionary policies that, according to
experts, violated provisions of the health regula-
tions (25). In relation to one of the biggest disease
crises of this century, parts of the International
Health Regulations were irrelevant, and other
parts were openly violated.
WHO’s reluctance to apply international law
has been attributed to its organizational culture,
which is dominated by scientists, doctors, and
medical experts. Perhaps the current weakness of
international law on infectious disease control
reflects WHO’s nonlegal strategy rather than the
inherent problems in international law itself. In
connection with emerging infections, however,
WHO is advocating an international legal strategy
by recommending revision of the International
Health Regulations (28). This recommendation
suggests that WHO acknowledges the need for
international legal agreement in dealing with
emerging infections. The global threat posed by
these infections represents in many ways a test
case for international public health law.
The Challenge to International Law
The threat of emerging infectious diseases
poses two challenges to international law: first, the
emerging infections problem exacerbates basic
weaknesses in the law. Second, these infections
pose specific difficulties in the law, which are re-
lated to the nature of disease and its prevention.
Basic Weaknesses
The effectiveness of international law depends
on the consent of states, which means that sover-
eignty and its exercise determine the fate of inter-
national legal rules (29). In adopting a legal
strategy for its emerging infectious disease action
plan, WHO has to convince its member states to
take certain actions in response to disease emer-
gence. The sovereignty of states looms large in
formulating a global response to emerging
infections, despite the fact that the process of
globalization undermines the sovereignty of the
state to deal nationally with these infections. In
other words, the problem by-passes the state, but
the solution has to rely on the state through the
medium of international law. The central impor-
tance of the state and its sovereignty constitutes
a basic weakness in international law because
international legal rules tend to reflect the com-
promises necessary to achieve agreement and the
unwillingness of states to restrict their freedom of
action through international law. Part of the rea-
son that the existing International Health Regu-
lations cover only a few diseases might be the
unwillingness of WHO member states to commit
to more serious infectious disease control meas-
ures. The vagueness and lack of specificity in the
so-called “right to health” also illustrate this prob-
lem. What is scientifically and medically neces-
sary to combat emerging diseases may not be what
states are willing to agree to undertake.
A second basic weakness follows from the “sov-
ereignty problem”—the lack of effective
enforcement of international law. States often
agree to an international legal obligation without
any serious intent of fulfilling it. The alleged fail-
ure of the International Health Regulations may
be due to the failure of WHO member states to
fulfill the duties they accepted. Neither the regu-
lations nor WHO has any power to enforce compli-
ance (25). An international legal regime on
emerging diseases would also face this enforce-
ment problem.
Specific Difficulties
The very nature of the emerging disease threat
poses special difficulties for international law. The
global scope of the problem necessitates agree-
ment by most states to control emerging diseases.
If any major country or group of countries does not
participate, a gap in the global surveillance and
control network threatens the efficacy of the entire
effort. The negotiation of agreements involving
many states is usually difficult, because each state
knows that its nonparticipation threatens the suc-
cess of the entire venture. This problem has oc-
curred in international environmental law, where
global regimes have been needed to deal ade-
quately with environmental threats, such as ozone
depletion.
A second specific difficulty arises from the ex-
tent of medical and scientific resources needed to
establish an effective global surveillance and
control network for emerging diseases. Funda-
mental aspects of the proposed action plans in-
volve improving surveillance networks, public
health infrastructures, scientific research, and
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medical and scientific training (Table 1). Some
states, particularly in the developing world, do not
have the medical, scientific, and financial re-
sources to undertake such measures. Unless more
affluent countries provide the resources, develop-
ing states may use the inequity of wealth in the
international system as an argument to compli-
cate negotiating a global agreement. The so-called
“North-South problem” has made the negotiation
of international environmental agreements more
difficult, as developing countries have bargained
for more lenient treatment or a transfer of re-
sources from affluent countries to help them im-
prove environmental protection. A similar
dynamic may appear in any negotiations for a
global emerging disease effort. The U.S. inter-
agency working group on emerging diseases has
observed that major U.S. contributions to develop-
ing countries for emerging disease control pur-
poses “is not a likely prospect during this period of
deficit reduction and downsizing” (19), which sug-
gests that resource availability will probably com-
plicate international efforts in this area.
The problems associated with using interna-
tional law in a global strategy to combat emerging
diseases raise the question whether international
law can provide an adequate foundation for the
control of these diseases. The uncomfortable posi-
tion of having no choice but to rely on international
law when its weaknesses are substantial high-
lights the importance of thinking through the in-
ternational legal aspects of a global emerging
disease plan carefully.
WHO’s Proposed Legal Strategy
WHO wants to revise the International Health
Regulations as part of its global emerging disease
strategy (28). WHO’s proposal deserves some criti-
cal attention. It is not clear that the organization
has adequate authority to incorporate comprehen-
sive emerging disease control measures within the
international regulations. Under Article 21 of the
WHO Constitution, the World Health Assembly
can adopt binding regulations in sanitary and
quarantine requirements and other procedures to
prevent the international spread of disease (22).
The World Health Assembly adopted the Interna-
tional Health Regulations under Article 21. While
Article 21 and the regulations are relevant to
emerging disease control efforts, it is doubtful
whether the regulations can serve as a foundation
for a comprehensive emerging disease control
plan. The disease-outbreak notification
requirements in the regulations could be ex-
panded to include more diseases, but nothing in
Article 21 gives the World Health Assembly the
authority to require WHO member states to
strengthen public health infrastructures, which is
considered critical in the emerging disease actions
plans proposed to date (Table 1). It has been ar-
gued that attempting to address such infrastruc-
ture problems “is a solution which cannot be
obtained by an international instrument but only
by the improvement of the health conditions of the
peoples of WHO’s member states” (30). But, as the
history of administering the International Health
Regulations has shown, notification requirements
have not worked satisfactorily and are weakened
by the absence of adequate public health re-
sources. Further, Article 22 of the WHO Constitu-
tion makes regulations promulgated under Article
21 automatically binding on WHO member states,
except for member states that reject such regula-
tions or make reservations thereto (31). Article 22
relates to the sovereignty problem and may deter
WHO member states from agreeing to serious
revisions of the regulations. Analysis of the regu-
lations may question the wisdom of using the
regulations as the legal basis for dealing with
emerging diseases.
The World Health Assembly has the power to
adopt conventions or agreements within WHO’s
competence (21). The Assembly could use this
authority to address aspects of the global emerg-
ing disease control strategy that cannot be han-
dled with a revision of the regulations. However,
parceling up emerging disease control measures
between the International Health Regulations
and separate agreements would be legally compli-
cated. Further, WHO has not used this power to
adopt conventions or agreements, which explains
its unwillingness to explore all legal options open
to it.
Possible Alternative Legal Strategies
Alternative legal strategies to revising the In-
ternational Health Regulations range from reli-
ance on the development of customary
international law to the adoption of multilateral
treaties specifically on emerging-disease control
(Table 2). An issue related to these alternative
approaches is the substantive nature of the obli-
gations contained in legal documents. We have to
ask not only how states might agree on control
rules but also what these states might agree to do.
The proposed revision of the regulations
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Table 2. Alternative international legal strategies to revising the International Health Regulations
Alternative legal strategies Possible advantages Possible disadvantages
1. WHA incorporates emerging
disease control as part of the
proposed World Health Charter
scheduled for initial negotiations
in 1997
Integrates emerging disease control
measures into the overall WHO
approach to international health
issues
a. Emerging disease control would
not be primary focus
b. World Health Charter is likely to
be more aspirational than
obligatory
2. WHA adopts an emerging
disease–specific convention under
Article 19 of the WHO Constitution
a. Avoids IHR model
b. Has potential to set out
comprehensive global approach
to emerging diseases
a. WHA has no experience with
using Article 19
b. Large multinational treaties tend
to contain general obligations
rather than specific duties
3. States negotiate a framework
multilateral treaty on general
emerging disease obligations,
accompanied by disease-specific or
region-specific protocols containing
detailed and specific commitments
on emerging disease control
a. Takes emerging disease control
out of WHO, eliminating
problem of WHO’s reluctance to
use international law
b. Allows for new protocols to be
adopted for new diseases
c. Framework-protocol approach
has been used with some success
in international environmental
law on ozone depletion
a. WHO has to play central role in
any emerging disease plan
b. Framework-protocol approach
might not be appropriate model
for emerging disease control
because the emerging disease
problem differs from ozone
depletion
4. Encourage regional arrangements
and integrate them into global
regime over time
a. Builds on strong regional systems
of cooperation and coordination
b. Offers “legal laboratories” to try
various approaches to emerging
disease control
c. Avoids diplomatic headaches
involved in trying to negotiate
truly global legal regimes
a. Emerging diseases require a
global approach not just a
regional approach
b. Amounts to emerging disease
control for rich regions, leaving
many developing countries
outside legal regime
c. Risks inconsistencies in how
emerging diseases are handled
by different regions
5. Encourage a bilateral approach in
which individual countries
negotiate detailed and specific
commitments on emerging
diseases and perhaps condition
trade benefits and aid on emerging
disease performance
a. Gives states flexibility in
constructing legal obligations
b. Permits possibility for sanctions
for failure to live up to emerging
disease obligations
a. Does not address global nature of
emerging disease problem
b. Sanctions element is unrealistic
and might be unfair to devel-
oping countries lacking
the resources necessary to
implement adequate emerging
disease control measures
6. Incorporate emerging disease
control as part of international
“right to health,” making emerging
diseases a human rights issue
a. Links emerging disease control
with larger, powerful concepts of
human welfare
b. Builds on existing international
law on the “right to health”
a. International “right to health” has
no definitive meaning or scope
and thus is a bad foundation for
emerging disease control
b. Human rights are inherently
divisive in the international
system; linkage with such a
controversial area would hurt
emerging disease control
prospects
7. Rely on customary international
law to develop emerging
disease-control norms
Customary international norms on
emerging disease control would be
binding on all states except persistent
objectors
a. It will be nearly impossible to
develop general and uniform state
practice recognized by states as
legally binding in the emerging
disease-control area
b. Any customary norms that might
form will probably be vague and
hard to identify definitively
c. Customary norms can take a very
long time to develop
WHA = World Health Assembly; WHO = World Health Organization; IHR = International Health Regulations.
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apparently would only apply the notification du-
ties (currently found in the regulations) to more
diseases. As indicated earlier, WHO cannot ad-
dress in its revision of the regulations any of the
improvements in public health infrastructures,
surveillance networks, scientific research, or
medical and scientific training at the heart of
proposed emerging disease action plans. Further,
it is not clear whether WHO intends to supplement
expanded notification duties with any mechanism
to monitor or enforce such duties.
International environmental law had to over-
come some of the same obstacles encountered by
WHO’s international legal effort for emerging dis-
ease control. States realized that they could not
handle global environmental problems without
international cooperation and rules (32). Further,
states knew that addressing environmental con-
cerns would require changes for governments and
companies within states and that developing
states might have financial and technological dif-
ficulties implementing international agreements
(32). In developing international environmental
law, states, international organizations, and
nongovernmental organizations did not rely on old
approaches but instead crafted new international
legal rules to deal with the global nature of the
threats posed, the resource issue, and compliance
and enforcement problems (33). Whether interna-
tional environmental law has been successful is
controversial; but it is important that states have
not been willing to admit that improving environ-
mental conditions within states is a solution that
cannot be obtained by international agreements.
Models and precedents from international envi-
ronmental law are not in all respects helpful to the
challenge of emerging-disease control; but, at the
very least, those grappling with an international
strategy for the emerging-disease threat could
analyze international environmental law and
other innovative legal responses to globalization
to look for ways of making WHO’s international
legal strategy on emerging diseases as effective as
possible.
Those currently designing global emerging-
disease control strategies will eventually have to
translate what is scientifically and medically
needed to combat these diseases into international
agreement and cooperation through international
law.The movement from science and medicine into
the realm of international law will not be easy.
Relying on the International Health Regulations
as the centerpiece of international law on emerg-
ing-disease control may not be the most effective
international legal strategy. Whatever interna-
tional legal approach is eventually taken will have
to confront somehow a fundamental paradox: glo-
balization jeopardizes disease control nationally
by eroding sovereignty, while the need for interna-
tional solutions allows sovereignty to frustrate
disease control internationally.The combination of
the process of globalization and the unavoidable
need to rely on international law produces a most
unattractive medium in which to wage potentially
one of the most important medical and scientific
endeavors in history.
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